MedCap AB (publ)

MCAP · Nasdaq Stockholm · Healthcare

511.50SEK −0.4%last day

Price as of 2 October 2026

The price over the past year, with dividends: −9.5%

Performance

1 month

−10.0%

1 year

−9.5%

3 years, per year

+22.4%

5 years, per year

+21.5%

Largest fall, 3 years

−45.8%

Below the peak now

−23.7%

Volatility, 1 year

34.7%

Return with dividends reinvested.

Key figures

P/E

30.7

P/B

4.7

Dividend yield

0.0%

Return on equity

+15.2%

Net margin

+10.7%

Market value

762 m USD

Quality, value and trend

Where MedCap stands against every Nordic stock today. 100 is best.

Quality98

Profitability and a sound balance sheet over time. Better than 98% of Nordic stocks.

Value25

The price measured against earnings, assets and cash flow. Better than 25% of Nordic stocks.

Trend57

The price development over the past year. Better than 57% of Nordic stocks.

Combined67

Quality, value and trend together. Better than 67% of Nordic stocks.

About MedCap

MedCap AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 650 employees.

MedCap AB (publ) is a private equity firm specializing in investments in secondary direct, later stage, industry consolidation, add-on acquisitions, growth capital, middle market, mature, turnarounds, and buyout. It prefers to invest in Biotechnology; Life sciences; Pharmaceuticals; MedTech including healthcare equipment, software, components, and packaging solutions for life science products; and Assistive Tech including digital and physical solutions in cognition, communication, environmental control, alarms, mobility, accessibility, and orthotics.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis